Elisa Rumi

Jul 28, 2023 | nature.com | Alessandra Carobbio |Elisa Rumi |Valerio De Stefano |Alessandro Rambaldi |Francesco Passamonti |Naseema Gangat | +1 more

Dear EditorAmple evidence has been provided that accurate discrimination between essential thrombocythemia (ET) and early prefibrotic primary myelofibrosis (pre-PMF) has an impact not only on presenting laboratory data but also on complications, like thrombosis, progression to overt myelofibrosis (MF), transformation to blast phase (BP), and overall survival [1,2,3,4,5,6,7,8].